APA (7th ed.) Citation

Pampusch, M. S., Abdelaal, H. M., Cartwright, E. K., Molden, J. S., Davey, B. C., Sauve, J. D., . . . Skinner, P. J. (2021, July 26). CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection bioRxiv. https://doi.org/10.1101/2021.07.26.453803

Chicago Style (17th ed.) Citation

Pampusch, Mary S., et al. "CAR/CXCR5-T Cell Immunotherapy Is Safe and Potentially Efficacious in Promoting Sustained Remission of SIV Infection." BioRxiv 26 Jul. 2021. https://doi.org/10.1101/2021.07.26.453803.

MLA (9th ed.) Citation

Pampusch, Mary S., et al. "CAR/CXCR5-T Cell Immunotherapy Is Safe and Potentially Efficacious in Promoting Sustained Remission of SIV Infection." BioRxiv, 26 Jul. 2021, https://doi.org/10.1101/2021.07.26.453803.